Different incidence of breast carcinomas or fibroadenomas in daunomycin or adriamycin treated rats.
D000230:Adenocarcinoma / Q000139:chemically induced*; D000232:Adenofibroma / Q000139:chemically induced; D000606:Amino Sugars / Q000009:adverse effects; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D003630:Daunorubicin / Q000009:adverse effects*; D005260:Female; D006027:Glycosides / Q000009:adverse effects; D007275:Injections, Intravenous; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced*; D009279:Naphthacenes / Q000009:adverse effects; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D000606:Amino Sugars; D000903:Antibiotics, Antineoplastic; D006027:Glycosides; D009279:Naphthacenes; D003630:Daunorubicin